ScoreWhy is Shenzhen Chipscreen Biosciences Co., Ltd. ?
1
The company is Net-Debt Free
- Poor long term growth as Net Sales has grown by an annual rate of 26.40% and Operating profit at 63.15% over the last 5 years
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 1.36% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of 26.40% and Operating profit at 63.15% over the last 5 years
3
The company has declared Positive results for the last 5 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at CNY 145.79 MM
- NET PROFIT(HY) Higher at CNY 69.97 MM
- ROCE(HY) Highest at 4.74%
4
With ROE of 3.77%, it has a expensive valuation with a 4.10 Price to Book Value
- Over the past year, while the stock has generated a return of -18.03%, its profits have risen by 184.4% ; the PEG ratio of the company is 0.6
5
Underperformed the market in the last 1 year
- Even though the market (China Shanghai Composite) has generated returns of 3.40% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -18.03% returns
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Shenzhen Chipscreen Biosciences Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Shenzhen Chipscreen Biosciences Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Shenzhen Chipscreen Biosciences Co., Ltd.
-19.42%
0.68
45.78%
China Shanghai Composite
3.23%
0.23
14.72%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
26.40%
EBIT Growth (5y)
63.15%
EBIT to Interest (avg)
-1.20
Debt to EBITDA (avg)
0.92
Net Debt to Equity (avg)
0.58
Sales to Capital Employed (avg)
0.23
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
46.36%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.03%
ROE (avg)
1.36%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
109
Industry P/E
Price to Book Value
4.10
EV to EBIT
78.77
EV to EBITDA
56.03
EV to Capital Employed
4.07
EV to Sales
10.58
PEG Ratio
0.59
Dividend Yield
0.22%
ROCE (Latest)
5.17%
ROE (Latest)
3.77%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend26What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 145.79 MM
NET PROFIT(HY)
Higher at CNY 69.97 MM
ROCE(HY)
Highest at 4.74%
RAW MATERIAL COST(Y)
Fallen by 0.77% (YoY
CASH AND EQV(HY)
Highest at CNY 3,017.56 MM
DEBT-EQUITY RATIO
(HY)
Lowest at 5.21 %
NET SALES(Q)
Highest at CNY 286.19 MM
OPERATING PROFIT(Q)
Highest at CNY 79.51 MM
PRE-TAX PROFIT(Q)
Highest at CNY 54.36 MM
-9What is not working for the Company
INTEREST(Q)
Highest at CNY 10.65 MM
Here's what is working for Shenzhen Chipscreen Biosciences Co., Ltd.
Net Profit
At CNY 69.97 MM has Grown at 136.45%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (CNY MM)
Operating Cash Flow
Highest at CNY 145.79 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Net Profit
Higher at CNY 69.97 MM
than preceding 12 month period ended Jun 2026MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (CNY MM)
Net Sales
Highest at CNY 286.19 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Operating Profit
Highest at CNY 79.51 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (CNY MM)
Pre-Tax Profit
Highest at CNY 54.36 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Cash and Eqv
Highest at CNY 3,017.56 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debt-Equity Ratio
Lowest at 5.21 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by 0.77% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Shenzhen Chipscreen Biosciences Co., Ltd.
Interest
At CNY 10.65 MM has Grown at 24.71%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Interest
Highest at CNY 10.65 MM
in the last five periods and Increased by 24.71% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Footer loading
